Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 259

1.

Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.

Resmini C, Di Cuia M, Ballocca F, D'Ascenzo F, Bollati M, Moretti C, Omedè PL, Sciuto F, Gaita F, Sheiban I.

Minerva Cardioangiol. 2012 Dec;60(6):573-80.

PMID:
23147435
[PubMed - indexed for MEDLINE]
2.

Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.

Kersting S, Grumann T, Hummel J, Hauschke D, Bode C, Hehrlein C.

Crit Pathw Cardiol. 2012 Sep;11(3):152-9. doi: 10.1097/HPC.0b013e31825d267a.

PMID:
22825536
[PubMed - indexed for MEDLINE]
3.

Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.

Wang CH, Fang Q, Zhang SY, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY, Xie HZ, Yang M.

Chin Med J (Engl). 2012 Aug;125(16):2803-6.

PMID:
22932070
[PubMed - indexed for MEDLINE]
Free Article
4.

One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.

Barthelemy O, Helft G, Silvain J, Bellemain-Appaix A, Beygui F, Choussat R, Berman E, Collet JP, Montalescot G, Metzger JP, Le Feuvre C.

Arch Cardiovasc Dis. 2011 Dec;104(12):604-10. doi: 10.1016/j.acvd.2011.05.010. Epub 2011 Nov 25.

PMID:
22152512
[PubMed - indexed for MEDLINE]
Free Article
5.

Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.

Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E.

Arch Cardiovasc Dis. 2013 Nov;106(11):554-61. doi: 10.1016/j.acvd.2013.06.056. Epub 2013 Nov 11.

PMID:
24231052
[PubMed - indexed for MEDLINE]
6.

A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions.

Colombo F, Biondi-Zoccai G, Infantino V, Omedé P, Moretti C, Sciuto F, Siliquini R, Chiadò S, Trevi GP, Sheiban I.

Acta Cardiol. 2009 Oct;64(5):583-8.

PMID:
20058502
[PubMed - indexed for MEDLINE]
7.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).

Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.

JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129. Epub 2013 May 15.

PMID:
23683734
[PubMed - indexed for MEDLINE]
Free Article
8.

Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.

Almalla M, Pross V, Marx N, Hoffmann R.

Coron Artery Dis. 2012 Nov;23(7):492-6.

PMID:
22990414
[PubMed - indexed for MEDLINE]
9.

Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

Saltzman AJ, Stone GW, Claessen BE, Narula A, Leon-Reyes S, Weisz G, Brodie B, Witzenbichler B, Guagliumi G, Kornowski R, Dudek D, Metzger DC, Lansky AJ, Nikolsky E, Dangas GD, Mehran R.

JACC Cardiovasc Interv. 2011 Sep;4(9):1011-9. doi: 10.1016/j.jcin.2011.06.012.

PMID:
21939942
[PubMed - indexed for MEDLINE]
Free Article
10.

Major adverse cardiac events in patients with hepatitis C infection treated with bare-metal versus drug-eluting stents.

Palaniswamy C, Aronow WS, Sukhija R, Chugh T, Ramdeen N, Kalapatapu K, Weiss MB, Pucillo AL, Monsen CE.

Clin Cardiol. 2010 Jun;33(6):367-70. doi: 10.1002/clc.20764.

PMID:
20556808
[PubMed - indexed for MEDLINE]
11.

Incidence and very long- term outcomes of stent thrombosis after bare-metal or drug-eluting stent implantation: a retrospective analysis.

Pullara A, Longo G, Gonella A, D'Ascenzo F, Biondi Zoccai G, Moretti C, Sciuto F, Omedè PL, Bollati M, Gaita F, Sheiban I.

Minerva Cardioangiol. 2013 Feb;61(1):1-9.

PMID:
23381375
[PubMed - indexed for MEDLINE]
12.

3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.

De Felice F, Fiorilli R, Parma A, Nazzaro M, Musto C, Sbraga F, Caferri G, Violini R.

JACC Cardiovasc Interv. 2009 Dec;2(12):1260-5. doi: 10.1016/j.jcin.2009.09.013.

PMID:
20129553
[PubMed - indexed for MEDLINE]
Free Article
13.

Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents in ST elevation myocardial infarction: findings from the Guthrie Health Off-label Stent (GHOST) Registry.

Sattur S, Orshaw P, Boura J, Harjai KJ.

J Interv Cardiol. 2012 Apr;25(2):118-25. doi: 10.1111/j.1540-8183.2011.00703.x. Epub 2012 Feb 10.

PMID:
22324820
[PubMed - indexed for MEDLINE]
14.

Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.

Jones DA, Rathod KS, Gallagher S, Weerackody R, Knight CJ, Rothman MT, Mathur A, Jain AK, Timmis AD, Wragg A.

Catheter Cardiovasc Interv. 2013 May;81(6):E237-44. doi: 10.1002/ccd.24513. Epub 2012 Nov 14.

PMID:
22707383
[PubMed - indexed for MEDLINE]
15.

In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.

Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF; EVENT Investigators.

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1127-36. doi: 10.1002/ccd.24352. Epub 2012 May 4.

PMID:
22431166
[PubMed - indexed for MEDLINE]
16.

Drug-eluting stents in patients with chronic kidney disease: a prospective registry study.

Shenoy C, Boura J, Orshaw P, Harjai KJ.

PLoS One. 2010 Nov 29;5(11):e15070. doi: 10.1371/journal.pone.0015070.

PMID:
21124771
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.

Jeong YH, Hong MK, Lee CW, Park DW, Kim YH, Kim JJ, Park SW, Park SJ.

Int J Cardiol. 2008 Mar 28;125(1):36-40. Epub 2007 May 22.

PMID:
17521753
[PubMed - indexed for MEDLINE]
18.

The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.

Simsek C, Magro M, Boersma E, Onuma Y, Nauta ST, Gaspersz MP, van der Giessen WJ, van Domburg RT, Serruys PW; Interventional Cardiologists of the Thoraxcenter.

JACC Cardiovasc Interv. 2010 Oct;3(10):1051-8. doi: 10.1016/j.jcin.2010.08.003.

PMID:
20965464
[PubMed - indexed for MEDLINE]
Free Article
19.

Long-term efficacy and safety of drug-eluting stent implantation for patients with multiple coronary chronic total occlusions.

Zhang J, Han YL, Li Y, Wang SL, Jing QM, Wang XZ, Ma YY, Luan B, Wang G, Wang B.

Chin Med J (Engl). 2010 Apr 5;123(7):789-93.

PMID:
20497665
[PubMed - indexed for MEDLINE]
Free Article
20.

Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients.

Ishii H, Toriyama T, Aoyama T, Takahashi H, Tanaka M, Yoshikawa D, Hayashi M, Yasuda Y, Maruyama S, Matsuo S, Matsubara T, Murohara T.

Circ J. 2012;76(7):1609-15. Epub 2012 Apr 7.

PMID:
22484980
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk